SCHEMBL4229585

SCHEMBL4229585

Cc1ccc(CN2CC[C@@H](Nc3ncc(C=CC(=O)NOC4CCCCO4)cc3Cl)C2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
ACHE P22303 1/20 0.38
SCN1A P35498 1/20 0.38
SCN8A Q9UQD0 1/20 0.38
TSHR P16473 1/20 0.38
MCHR1 Q99705 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
HTR2A P28223 1/20 0.37
ROCK2 O75116 4/20 0.36
CCR2 P41597 2/20 0.36
CCR3 P51677 1/20 0.36
SSTR5 P35346 3/20 0.36
SSTR1 P30872 1/20 0.36
HRH1 P35367 1/20 0.36
HDAC1 Q13547 2/20 0.36
EHMT1 Q9H9B1 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229579 1.00 MAOA (0.38) MAOAMAOBACHESCN1ASCN8A
SCHEMBL4222444 0.96 MCHR1 (0.41) MAOAMAOBACHETSHRMCHR1
SCHEMBL4222452 0.96 MCHR1 (0.41) MAOAMAOBACHETSHRMCHR1
SCHEMBL4221070 0.94 SCN8A (0.40) MAOAMAOBSCN1ASCN8ADRD4
SCHEMBL4221078 0.94 SCN8A (0.40) MAOAMAOBSCN1ASCN8ADRD4
SCHEMBL4222071 0.93 JAK1 (0.42) MAOAMAOBACHEMCHR1ROCK2
SCHEMBL4222062 0.93 JAK1 (0.42) MAOAMAOBACHEMCHR1ROCK2
SCHEMBL4228371 0.93 CCR3 (0.42) MAOAMAOBACHESCN1ASCN8A
SCHEMBL4228366 0.93 CCR3 (0.42) MAOAMAOBACHESCN1ASCN8A
SCHEMBL4217956 0.93 SCN1A (0.45) MAOAMAOBACHESCN1ASCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557127-B2 HDAC inhibitor ASTELLAS PHARMA INC. (JP) 2009-07-07 US disclosed
US-20090054464-A1 HDAC INHIBITOR ASTELLAS PHARMA INC. (JP) 2009-02-26 US disclosed
US-7465731-B2 HDAC inhibitor ASTELLAS PHARMA INC. (JP) 2008-12-16 US disclosed
US-20060052599-A1 HDAC inhibitor ASTELLAS PHARMA INC. (JP) 2006-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052599-A1 HDAC inhibitor HDAC1, HDAC2, HDAC11 MAOA 823/4885MAOB 956/4885ACHE 4051/4885
US-20090054464-A1 HDAC INHIBITOR HDAC1, HDAC2, HDAC8 MAOA 515/4885MAOB 535/4885ACHE 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.